- About
- Organization
- Organization Overview
- Dean’s Office
- Department of Bioengineering and Therapeutic Sciences
- Department of Clinical Pharmacy
- Department of Pharmaceutical Chemistry
- Quantitative Biosciences Institute
- Org Chart
- Research
- Education
- Patient Care
- People
- News
- Events
Problems with Medicare Part D rollout explained
By UCSF School of Pharmacy Editorial Staff / Fri Jan 20, 2006
Marilyn Stebbins, PharmD, UCSF School of Pharmacy clinical professor and drug benefit expert, explains the problems as of January 2006 with the rollout of the Medicare Part D drug benefit. She advises seniors on how to get the medication coverage that best meets their needs. • Full story: Confused by Medicare Part D? UCSF Expert Offers Advice.
More information:
[Rx Drug Benefit & Medication Therapy Managment: A Resource for Health Professionals, Faculty, and Patients] [link defunct].
Tags
Topics:
Category:
Sites:
School of Pharmacy, Department of Clinical Pharmacy, PharmD Degree Program
About the School: The UCSF School of Pharmacy aims to solve the most pressing health care problems and strives to ensure that each patient receives the safest, most effective treatments. Our discoveries seed the development of novel therapies, and our researchers consistently lead the nation in NIH funding. The School’s doctor of pharmacy (PharmD) degree program, with its unique emphasis on scientific thinking, prepares students to be critical thinkers and leaders in their field.
